2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple MyelomaHigh-Risk de Novo Multiple MyelomaActive, not recruitingPhase 22026-05-11NCT05849610
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, lung disorder, respiratory system disorderRecruitingPhase 22025-03-17NCT06270199